FORTIS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Fortis Healthcare reported strong audited consolidated financial results for FY2026 ending March 31. Total income grew to Rs 91,785 crore, up 17% from Rs 78,497 crore in FY2025. Net profit increased 31% to Rs 1,064 crore from Rs 809 crore. The Board approved appointment of M/s Jitender, Navneet & Co., Cost Accountants as Cost Auditor for FY2026-27. A final dividend of Rs 1 per share (10% on Rs 10 face value) has been recommended, subject to shareholder approval. The company operates two segments - Healthcare (Revenue Rs 77,727 crore, segment profit Rs 13,937 crore) and Diagnostics (Revenue Rs 15,266 crore, segment profit Rs 2,419 crore). Statutory auditors B S R & Co. LLP issued an unmodified opinion, though they highlighted ongoing SFIO investigation related to alleged improper transactions from the pre-2018 period.
Positive financial performance with strong revenue and profit growth. The dividend and cost auditor appointment are routine matters. SFIO investigation from past transactions remains a governance overhang but is not expected to have material further impact as per management.